KRRO MEXC RealStocks
Own real KRRO shares through MEXC's regulated brokerage partner.
Suitable for long-term holding.
- Own the actual shares
- Receive dividends and voting rights
- Buy fractional shares starting at $1
Last updated: 2026-11-19 07:21:20. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
Korro Bio, Inc. (KRRO) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $12.43, with a market capitalization of $169.10M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $5.20 to $17.35. This page covers its latest market performance, valuation, price trends and company information.
$169.10M | |
$12.19 | |
$13.35 | |
$12.07 | |
$12.32 | |
123.79K | |
186.12K | |
-- | |
$17.35 | |
$5.20 | |
-- | |
2026-09-30 |
Korro Bio, Inc. (KRRO) last closed at $12.43 as of 2026-11-19 00:31:00, up 1.14% ($0.14) from the previous close of $12.32.
During the latest regular trading session, KRRO traded between $12.07 and $13.35, with a volume of 123.79K shares. The closing price was near the lower end and near the middle of its 52-week range.
Over the past seven days, Korro Bio, Inc. (KRRO) moved from $15.73 to $12.43, representing a decline of 21.01% ($3.30).
The stock traded between $11.85 and $16.00 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.
The average daily volume was 155.62 thousand shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 59.4%
KRRO is currently trading at $12.43, placing it 59.4% of the way from its 52-week low of $5.20 to its 52-week high of $17.35. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Korro Bio Inc is a biopharmaceutical company with a mission to discover, develop, and commercialize a new class of genetic medicines based on editing RNA, enabling the treatment of both rare and highly prevalent diseases. It is generating a portfolio of differentiated programs that are designed to harness the body's natural RNA editing process to effect a precise yet transient single base edit. By editing RNA instead of DNA, Korro Bio is expanding the reach of genetic medicines by delivering additional precision and tunability. The company operates and manages its business as one reportable segment and one operating segment, which is the business of discovering, developing and commercializing therapies derived from or incorporating its RNA-editing technology.
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 57 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of Korro Bio, Inc. (KRRO) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Stock prices and market data on this page, including price changes and market status, are provided by Massive and other third-party news and data platforms. Market data may be delayed and may differ from prices on other platforms or the prices at which trades are executed on MEXC. MEXC does not guarantee the accuracy, completeness, or timeliness of third-party data. MEXC offers trading products related to KRRO, including Stocks, Tokenized Stocks, and Stock Futures.
The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.
Estimate the value between KRRO shares and USD.
KRRO Shares to USD
1.00 KRRO shares = 12.425 USD
Calculations are estimates based on the latest available price and are for reference only.